line_item,period,value,symbol
Tax Effect Of Unusual Items,2024-03-31 00:00:00,-293771.157932,MEDIORG.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.290575,MEDIORG.NS
Normalized EBITDA,2024-03-31 00:00:00,48331000.0,MEDIORG.NS
Total Unusual Items,2024-03-31 00:00:00,-1011000.0,MEDIORG.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,-1011000.0,MEDIORG.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,24041000.0,MEDIORG.NS
Reconciled Depreciation,2024-03-31 00:00:00,7194000.0,MEDIORG.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,157986000.0,MEDIORG.NS
EBITDA,2024-03-31 00:00:00,47320000.0,MEDIORG.NS
EBIT,2024-03-31 00:00:00,40126000.0,MEDIORG.NS
Net Interest Income,2024-03-31 00:00:00,-6340000.0,MEDIORG.NS
Interest Expense,2024-03-31 00:00:00,6238000.0,MEDIORG.NS
Interest Income,2024-03-31 00:00:00,134000.0,MEDIORG.NS
Normalized Income,2024-03-31 00:00:00,24758228.842068,MEDIORG.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,24041000.0,MEDIORG.NS
Total Expenses,2024-03-31 00:00:00,211523000.0,MEDIORG.NS
Rent Expense Supplemental,2024-03-31 00:00:00,426000.0,MEDIORG.NS
Diluted Average Shares,2024-03-31 00:00:00,,MEDIORG.NS
Basic Average Shares,2024-03-31 00:00:00,,MEDIORG.NS
Diluted EPS,2024-03-31 00:00:00,,MEDIORG.NS
Basic EPS,2024-03-31 00:00:00,,MEDIORG.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,24041000.0,MEDIORG.NS
Net Income Common Stockholders,2024-03-31 00:00:00,24041000.0,MEDIORG.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,MEDIORG.NS
Net Income,2024-03-31 00:00:00,24041000.0,MEDIORG.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,24041000.0,MEDIORG.NS
Net Income Continuous Operations,2024-03-31 00:00:00,24041000.0,MEDIORG.NS
Tax Provision,2024-03-31 00:00:00,9847000.0,MEDIORG.NS
Pretax Income,2024-03-31 00:00:00,33888000.0,MEDIORG.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,28000.0,MEDIORG.NS
Special Income Charges,2024-03-31 00:00:00,-1011000.0,MEDIORG.NS
Write Off,2024-03-31 00:00:00,1011000.0,MEDIORG.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-6340000.0,MEDIORG.NS
Total Other Finance Cost,2024-03-31 00:00:00,236000.0,MEDIORG.NS
Interest Expense Non Operating,2024-03-31 00:00:00,6238000.0,MEDIORG.NS
Interest Income Non Operating,2024-03-31 00:00:00,134000.0,MEDIORG.NS
Operating Income,2024-03-31 00:00:00,41194000.0,MEDIORG.NS
Operating Expense,2024-03-31 00:00:00,53537000.0,MEDIORG.NS
Other Operating Expenses,2024-03-31 00:00:00,24000.0,MEDIORG.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,7194000.0,MEDIORG.NS
Depreciation Income Statement,2024-03-31 00:00:00,7194000.0,MEDIORG.NS
Selling General And Administration,2024-03-31 00:00:00,12354000.0,MEDIORG.NS
Selling And Marketing Expense,2024-03-31 00:00:00,1936000.0,MEDIORG.NS
General And Administrative Expense,2024-03-31 00:00:00,10418000.0,MEDIORG.NS
Rent And Landing Fees,2024-03-31 00:00:00,426000.0,MEDIORG.NS
Gross Profit,2024-03-31 00:00:00,94731000.0,MEDIORG.NS
Cost Of Revenue,2024-03-31 00:00:00,157986000.0,MEDIORG.NS
Total Revenue,2024-03-31 00:00:00,252717000.0,MEDIORG.NS
Operating Revenue,2024-03-31 00:00:00,252717000.0,MEDIORG.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,2298700.007355,MEDIORG.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.287122,MEDIORG.NS
Normalized EBITDA,2023-03-31 00:00:00,18365000.0,MEDIORG.NS
Total Unusual Items,2023-03-31 00:00:00,8006000.0,MEDIORG.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,8006000.0,MEDIORG.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,9693000.0,MEDIORG.NS
Reconciled Depreciation,2023-03-31 00:00:00,7116000.0,MEDIORG.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,157972000.0,MEDIORG.NS
EBITDA,2023-03-31 00:00:00,26371000.0,MEDIORG.NS
EBIT,2023-03-31 00:00:00,19255000.0,MEDIORG.NS
Net Interest Income,2023-03-31 00:00:00,-6043000.0,MEDIORG.NS
Interest Expense,2023-03-31 00:00:00,5658000.0,MEDIORG.NS
Interest Income,2023-03-31 00:00:00,81000.0,MEDIORG.NS
Normalized Income,2023-03-31 00:00:00,3985700.007355,MEDIORG.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,9693000.0,MEDIORG.NS
Total Expenses,2023-03-31 00:00:00,209761000.0,MEDIORG.NS
Rent Expense Supplemental,2023-03-31 00:00:00,406000.0,MEDIORG.NS
Diluted Average Shares,2023-03-31 00:00:00,11700000.0,MEDIORG.NS
Basic Average Shares,2023-03-31 00:00:00,11700000.0,MEDIORG.NS
Diluted EPS,2023-03-31 00:00:00,0.828462,MEDIORG.NS
Basic EPS,2023-03-31 00:00:00,0.828462,MEDIORG.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,9693000.0,MEDIORG.NS
Net Income Common Stockholders,2023-03-31 00:00:00,9693000.0,MEDIORG.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,MEDIORG.NS
Net Income,2023-03-31 00:00:00,9693000.0,MEDIORG.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,9693000.0,MEDIORG.NS
Net Income Continuous Operations,2023-03-31 00:00:00,9693000.0,MEDIORG.NS
Tax Provision,2023-03-31 00:00:00,3904000.0,MEDIORG.NS
Pretax Income,2023-03-31 00:00:00,13597000.0,MEDIORG.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,66000.0,MEDIORG.NS
Special Income Charges,2023-03-31 00:00:00,8006000.0,MEDIORG.NS
Write Off,2023-03-31 00:00:00,-8006000.0,MEDIORG.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-6043000.0,MEDIORG.NS
Total Other Finance Cost,2023-03-31 00:00:00,466000.0,MEDIORG.NS
Interest Expense Non Operating,2023-03-31 00:00:00,5658000.0,MEDIORG.NS
Interest Income Non Operating,2023-03-31 00:00:00,81000.0,MEDIORG.NS
Operating Income,2023-03-31 00:00:00,11710000.0,MEDIORG.NS
Operating Expense,2023-03-31 00:00:00,51789000.0,MEDIORG.NS
Other Operating Expenses,2023-03-31 00:00:00,39000.0,MEDIORG.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,7116000.0,MEDIORG.NS
Depreciation Income Statement,2023-03-31 00:00:00,7116000.0,MEDIORG.NS
Selling General And Administration,2023-03-31 00:00:00,12565000.0,MEDIORG.NS
Selling And Marketing Expense,2023-03-31 00:00:00,3922000.0,MEDIORG.NS
General And Administrative Expense,2023-03-31 00:00:00,8643000.0,MEDIORG.NS
Rent And Landing Fees,2023-03-31 00:00:00,406000.0,MEDIORG.NS
Gross Profit,2023-03-31 00:00:00,63499000.0,MEDIORG.NS
Cost Of Revenue,2023-03-31 00:00:00,157972000.0,MEDIORG.NS
Total Revenue,2023-03-31 00:00:00,221471000.0,MEDIORG.NS
Operating Revenue,2023-03-31 00:00:00,221471000.0,MEDIORG.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,564600.0,MEDIORG.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.3,MEDIORG.NS
Normalized EBITDA,2022-03-31 00:00:00,11828000.0,MEDIORG.NS
Total Unusual Items,2022-03-31 00:00:00,1882000.0,MEDIORG.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,1882000.0,MEDIORG.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,1014000.0,MEDIORG.NS
Reconciled Depreciation,2022-03-31 00:00:00,6801000.0,MEDIORG.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,156597000.0,MEDIORG.NS
EBITDA,2022-03-31 00:00:00,13710000.0,MEDIORG.NS
EBIT,2022-03-31 00:00:00,6909000.0,MEDIORG.NS
Net Interest Income,2022-03-31 00:00:00,-4499000.0,MEDIORG.NS
Interest Expense,2022-03-31 00:00:00,4357000.0,MEDIORG.NS
Interest Income,2022-03-31 00:00:00,233000.0,MEDIORG.NS
Normalized Income,2022-03-31 00:00:00,-303400.0,MEDIORG.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,1014000.0,MEDIORG.NS
Total Expenses,2022-03-31 00:00:00,204574000.0,MEDIORG.NS
Rent Expense Supplemental,2022-03-31 00:00:00,339000.0,MEDIORG.NS
Diluted Average Shares,2022-03-31 00:00:00,11700000.0,MEDIORG.NS
Basic Average Shares,2022-03-31 00:00:00,11700000.0,MEDIORG.NS
Diluted EPS,2022-03-31 00:00:00,0.086667,MEDIORG.NS
Basic EPS,2022-03-31 00:00:00,0.086667,MEDIORG.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,1014000.0,MEDIORG.NS
Net Income Common Stockholders,2022-03-31 00:00:00,1014000.0,MEDIORG.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,MEDIORG.NS
Net Income,2022-03-31 00:00:00,1014000.0,MEDIORG.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,1014000.0,MEDIORG.NS
Net Income Continuous Operations,2022-03-31 00:00:00,1014000.0,MEDIORG.NS
Tax Provision,2022-03-31 00:00:00,1538000.0,MEDIORG.NS
Pretax Income,2022-03-31 00:00:00,2552000.0,MEDIORG.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,,MEDIORG.NS
Special Income Charges,2022-03-31 00:00:00,1882000.0,MEDIORG.NS
Write Off,2022-03-31 00:00:00,-1882000.0,MEDIORG.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-4499000.0,MEDIORG.NS
Total Other Finance Cost,2022-03-31 00:00:00,375000.0,MEDIORG.NS
Interest Expense Non Operating,2022-03-31 00:00:00,4357000.0,MEDIORG.NS
Interest Income Non Operating,2022-03-31 00:00:00,233000.0,MEDIORG.NS
Operating Income,2022-03-31 00:00:00,5178000.0,MEDIORG.NS
Operating Expense,2022-03-31 00:00:00,47977000.0,MEDIORG.NS
Other Operating Expenses,2022-03-31 00:00:00,49000.0,MEDIORG.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,6801000.0,MEDIORG.NS
Depreciation Income Statement,2022-03-31 00:00:00,6801000.0,MEDIORG.NS
Selling General And Administration,2022-03-31 00:00:00,12052000.0,MEDIORG.NS
Selling And Marketing Expense,2022-03-31 00:00:00,4052000.0,MEDIORG.NS
General And Administrative Expense,2022-03-31 00:00:00,8000000.0,MEDIORG.NS
Rent And Landing Fees,2022-03-31 00:00:00,339000.0,MEDIORG.NS
Gross Profit,2022-03-31 00:00:00,53155000.0,MEDIORG.NS
Cost Of Revenue,2022-03-31 00:00:00,156597000.0,MEDIORG.NS
Total Revenue,2022-03-31 00:00:00,209752000.0,MEDIORG.NS
Operating Revenue,2022-03-31 00:00:00,209752000.0,MEDIORG.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,-1390582.959641,MEDIORG.NS
Tax Rate For Calcs,2021-03-31 00:00:00,0.392377,MEDIORG.NS
Normalized EBITDA,2021-03-31 00:00:00,19690000.0,MEDIORG.NS
Total Unusual Items,2021-03-31 00:00:00,-3544000.0,MEDIORG.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,-3544000.0,MEDIORG.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,2981000.0,MEDIORG.NS
Reconciled Depreciation,2021-03-31 00:00:00,6784000.0,MEDIORG.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,187604000.0,MEDIORG.NS
EBITDA,2021-03-31 00:00:00,16146000.0,MEDIORG.NS
EBIT,2021-03-31 00:00:00,9362000.0,MEDIORG.NS
Net Interest Income,2021-03-31 00:00:00,-4331000.0,MEDIORG.NS
Interest Expense,2021-03-31 00:00:00,4456000.0,MEDIORG.NS
Interest Income,2021-03-31 00:00:00,125000.0,MEDIORG.NS
Normalized Income,2021-03-31 00:00:00,5134417.040359,MEDIORG.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,2981000.0,MEDIORG.NS
Total Expenses,2021-03-31 00:00:00,237381000.0,MEDIORG.NS
Rent Expense Supplemental,2021-03-31 00:00:00,228000.0,MEDIORG.NS
Diluted Average Shares,2021-03-31 00:00:00,11700000.0,MEDIORG.NS
Basic Average Shares,2021-03-31 00:00:00,11700000.0,MEDIORG.NS
Diluted EPS,2021-03-31 00:00:00,0.254786,MEDIORG.NS
Basic EPS,2021-03-31 00:00:00,0.254786,MEDIORG.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,2981000.0,MEDIORG.NS
Net Income Common Stockholders,2021-03-31 00:00:00,2981000.0,MEDIORG.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,0.0,MEDIORG.NS
Net Income,2021-03-31 00:00:00,2981000.0,MEDIORG.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,2981000.0,MEDIORG.NS
Net Income Continuous Operations,2021-03-31 00:00:00,2981000.0,MEDIORG.NS
Tax Provision,2021-03-31 00:00:00,1925000.0,MEDIORG.NS
Pretax Income,2021-03-31 00:00:00,4906000.0,MEDIORG.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,MEDIORG.NS
Special Income Charges,2021-03-31 00:00:00,-3544000.0,MEDIORG.NS
Write Off,2021-03-31 00:00:00,3544000.0,MEDIORG.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,-4331000.0,MEDIORG.NS
Total Other Finance Cost,2021-03-31 00:00:00,,MEDIORG.NS
Interest Expense Non Operating,2021-03-31 00:00:00,4456000.0,MEDIORG.NS
Interest Income Non Operating,2021-03-31 00:00:00,125000.0,MEDIORG.NS
Operating Income,2021-03-31 00:00:00,13090000.0,MEDIORG.NS
Operating Expense,2021-03-31 00:00:00,49777000.0,MEDIORG.NS
Other Operating Expenses,2021-03-31 00:00:00,102000.0,MEDIORG.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,6784000.0,MEDIORG.NS
Depreciation Income Statement,2021-03-31 00:00:00,6784000.0,MEDIORG.NS
Selling General And Administration,2021-03-31 00:00:00,14720000.0,MEDIORG.NS
Selling And Marketing Expense,2021-03-31 00:00:00,5588000.0,MEDIORG.NS
General And Administrative Expense,2021-03-31 00:00:00,9132000.0,MEDIORG.NS
Rent And Landing Fees,2021-03-31 00:00:00,228000.0,MEDIORG.NS
Gross Profit,2021-03-31 00:00:00,62867000.0,MEDIORG.NS
Cost Of Revenue,2021-03-31 00:00:00,187604000.0,MEDIORG.NS
Total Revenue,2021-03-31 00:00:00,250471000.0,MEDIORG.NS
Operating Revenue,2021-03-31 00:00:00,250471000.0,MEDIORG.NS
